AI Applications in Drug Development and Approval Processes
Expert-defined terms from the Professional Certificate in Artificial Intelligence in Regulatory Affairs course at LearnUNI. Free to read, free to share, paired with a professional course.
A2C #
Advantage Actor-Critic is a type of reinforcement learning algorithm used in AI applications, including drug development and approval processes, to improve the efficiency of clinical trials and optimize treatment strategies. Related terms include Q-learning, policy gradients, and deep reinforcement learning.
ABE #
Actual Benefit Evaluation is a statistical method used to evaluate the effectiveness of a new treatment or drug, which is essential in the approval process of new drugs. Related terms include intent-to-treat, per-protocol analysis, and as-treated analysis.
AE #
Adverse Event is an unfavorable change in the health of a participant in a clinical trial, which is crucial in the development and approval of new drugs. Related terms include serious adverse event, adverse reaction, and side effect.
AI #
Artificial Intelligence refers to the simulation of human intelligence in machines, which is increasingly used in drug development and approval processes to improve efficiency and accuracy. Related terms include machine learning, deep learning, and natural language processing.
ANOVA #
Analysis of Variance is a statistical method used to compare means of three or more samples, which is commonly used in clinical trials to evaluate the effectiveness of new treatments. Related terms include t-test, regression analysis, and non-parametric tests.
API #
Application Programming Interface is a set of rules and protocols that enables different software systems to communicate with each other, which is essential in the integration of AI applications in drug development and approval processes. Related terms include data exchange, interoperability, and software development.
Bayesian #
Bayesian methods are a type of statistical approach that uses Bayes' theorem to update the probability of a hypothesis based on new data, which is increasingly used in clinical trials to evaluate the effectiveness of new treatments. Related terms include frequentist, likelihood, and prior distribution.
Biomarker #
A biomarker is a measurable characteristic that reflects the severity or presence of a disease, which is essential in the development and approval of new drugs. Related terms include surrogate endpoint, clinical endpoint, and pharmacodynamic marker.
CDISC #
Clinical Data Interchange Standards Consortium is an organization that develops and maintains data standards for clinical trials, which is essential in the integration of AI applications in drug development and approval processes. Related terms include data standardization, data exchange, and regulatory compliance.
CDRH #
Center for Devices and Radiological Health is a division of the US FDA that regulates medical devices, including software and AI applications used in drug development and approval processes. Related terms include FDA, regulatory affairs, and medical device regulation.
Clinical Trial #
A clinical trial is a research study that evaluates the safety and effectiveness of a new treatment or drug, which is essential in the development and approval of new drugs. Related terms include protocol, informed consent, and Institutional Review Board.
CNN #
Convolutional Neural Network is a type of deep learning algorithm used in AI applications, including image analysis and signal processing, which is increasingly used in drug development and approval processes. Related terms include image recognition, object detection, and segmentation.
CNS #
Central Nervous System is a complex system that includes the brain and spinal cord, which is a common target for new drugs and treatments. Related terms include neurology, psychiatry, and neuropharmacology.
CTC #
Clinical Trial Certificate is a document that confirms the compliance of a clinical trial with regulatory requirements, which is essential in the approval process of new drugs. Related terms include regulatory compliance, clinical trial management, and quality assurance.
Data Mining #
Data mining is the process of discovering patterns and relationships in large datasets, which is increasingly used in drug development and approval processes to identify potential safety issues and optimize treatment strategies. Related terms include machine learning, predictive analytics, and business intelligence.
Data Quality #
Data quality refers to the accuracy, completeness, and consistency of data, which is essential in the integration of AI applications in drug development and approval processes. Related terms include data validation, data cleaning, and data standardization.
Data Standardization #
Data standardization is the process of converting data into a standard format, which is essential in the integration of AI applications in drug development and approval processes. Related terms include data exchange, interoperability, and regulatory compliance.
DL #
Deep Learning is a type of machine learning algorithm that uses neural networks to analyze complex data, which is increasingly used in drug development and approval processes to improve efficiency and accuracy. Related terms include convolutional neural networks, recurrent neural networks, and natural language processing.
DMF #
Drug Master File is a document that contains detailed information about a drug, including its composition, manufacture, and quality control, which is essential in the approval process of new drugs. Related terms include regulatory compliance, quality assurance, and good manufacturing practice.
DMP #
Data Management Plan is a document that outlines the procedures for managing data in a clinical trial, which is essential in the integration of AI applications in drug development and approval processes. Related terms include data quality, data standardization, and regulatory compliance.
Dossier #
A dossier is a collection of documents that contains detailed information about a drug, including its safety, efficacy, and quality, which is essential in the approval process of new drugs. Related terms include regulatory submission, marketing authorization, and good manufacturing practice.
DSMB #
Data and Safety Monitoring Board is a committee that reviews data from a clinical trial to ensure the safety of participants and the integrity of the data, which is essential in the conduct of clinical trials. Related terms include safety monitoring, data monitoring, and clinical trial management.
EDC #
Electronic Data Capture is a system that enables the electronic collection and management of data in clinical trials, which is increasingly used in drug development and approval processes to improve efficiency and accuracy. Related terms include electronic health records, clinical trial management, and data quality.
EDF #
Electronic Data File is a file that contains electronic data from a clinical trial, which is essential in the integration of AI applications in drug development and approval processes.
EMA #
European Medicines Agency is a regulatory agency that evaluates and approves new drugs in the European Union, which is essential in the approval process of new drugs. Related terms include FDA, regulatory affairs, and marketing authorization.
FDA #
Food and Drug Administration is a regulatory agency that evaluates and approves new drugs in the United States, which is essential in the approval process of new drugs. Related terms include EMA, regulatory affairs, and marketing authorization.
GCP #
Good Clinical Practice is a set of guidelines that ensures the quality and integrity of clinical trials, which is essential in the conduct of clinical trials. Related terms include regulatory compliance, quality assurance, and clinical trial management.
GMP #
Good Manufacturing Practice is a set of guidelines that ensures the quality and safety of pharmaceuticals, which is essential in the approval process of new drugs. Related terms include regulatory compliance, quality assurance, and manufacturing process.
HPC #
High-Performance Computing is a type of computing that enables the rapid analysis of large datasets, which is increasingly used in drug development and approval processes to improve efficiency and accuracy. Related terms include cloud computing, data analytics, and machine learning.
ICH #
International Conference on Harmonisation is an organization that develops and maintains guidelines for the conduct of clinical trials, which is essential in the integration of AI applications in drug development and approval processes. Related terms include regulatory compliance, quality assurance, and good clinical practice.
IDMP #
Identification of Medicinal Products is a standard that enables the unique identification of medicinal products, which is essential in the approval process of new drugs. Related terms include regulatory compliance, quality assurance, and pharmacovigilance.
IE #
Information Extraction is the process of extracting relevant information from large datasets, which is increasingly used in drug development and approval processes to identify potential safety issues and optimize treatment strategies. Related terms include natural language processing, machine learning, and data mining.
IND #
Investigational New Drug is an application that is submitted to the FDA to initiate a clinical trial, which is essential in the development and approval of new drugs. Related terms include regulatory submission, clinical trial management, and good clinical practice.
IRB #
Institutional Review Board is a committee that reviews and approves clinical trials to ensure the safety and welfare of participants, which is essential in the conduct of clinical trials. Related terms include regulatory compliance, quality assurance, and informed consent.
ISPE #
International Society for Pharmaceutical Engineering is an organization that develops and maintains guidelines for the manufacture of pharmaceuticals, which is essential in the approval process of new drugs.
KDD #
Knowledge Discovery in Databases is the process of identifying patterns and relationships in large datasets, which is increasingly used in drug development and approval processes to identify potential safety issues and optimize treatment strategies. Related terms include data mining, machine learning, and business intelligence.
Labelling #
Labelling refers to the process of creating and reviewing labels for pharmaceuticals, which is essential in the approval process of new drugs.
LOCF #
Last Observation Carried Forward is a method that is used to handle missing data in clinical trials, which is essential in the analysis and interpretation of clinical trial data.
Machine Learning #
Machine learning is a type of artificial intelligence that enables machines to learn from data, which is increasingly used in drug development and approval processes to improve efficiency and accuracy. Related terms include deep learning, natural language processing, and predictive analytics.
MAE #
Maximum Allowable Error is a statistical method that is used to evaluate the accuracy of a measurement, which is essential in the analysis and interpretation of clinical trial data. Related terms include regulatory compliance, quality assurance, and good laboratory practice.
Marketing Authorization #
Marketing authorization is the process of obtaining approval to market a new drug, which is essential in the approval process of new drugs. Related terms include regulatory submission, dossier, and good manufacturing practice.
MDR #
Medical Device Regulation is a regulation that governs the development and approval of medical devices, including software and AI applications used in drug development and approval processes.
MedDRA #
Medical Dictionary for Regulatory Activities is a dictionary that provides a standardized terminology for adverse event reporting, which is essential in the approval process of new drugs.
Metadata #
Metadata refers to data that provides information about other data, which is essential in the integration of AI applications in drug development and approval processes.
ML #
Machine Learning is a type of artificial intelligence that enables machines to learn from data, which is increasingly used in drug development and approval processes to improve efficiency and accuracy.
MRA #
Mutual Recognition Agreement is an agreement that enables the mutual recognition of regulatory decisions between countries, which is essential in the approval process of new drugs.
NDA #
New Drug Application is an application that is submitted to the FDA to obtain approval for a new drug, which is essential in the approval process of new drugs.
Neural Network #
A neural network is a type of machine learning algorithm that is modeled on the human brain, which is increasingly used in drug development and approval processes to improve efficiency and accuracy. Related terms include deep learning, convolutional neural networks, and natural language processing.
NLP #
Natural Language Processing is a type of artificial intelligence that enables machines to understand and generate human language, which is increasingly used in drug development and approval processes to improve efficiency and accuracy. Related terms include machine learning, deep learning, and text mining.
Non #
Clinical: Non-clinical refers to studies that are conducted outside of a clinical trial, which is essential in the development and approval of new drugs. Related terms include preclinical, toxicology, and pharmacokinetics.
NPV #
Negative Predictive Value is a statistical method that is used to evaluate the accuracy of a diagnostic test, which is essential in the analysis and interpretation of clinical trial data. Related terms include sensitivity, specificity, and positive predictive value.
OCR #
Optical Character Recognition is a technology that enables the conversion of scanned documents into electronic text, which is increasingly used in drug development and approval processes to improve efficiency and accuracy.
ODS #
Operational Data Store is a database that provides a centralized repository for clinical trial data, which is essential in the integration of AI applications in drug development and approval processes.
OLAP #
Online Analytical Processing is a technology that enables the analysis of large datasets, which is increasingly used in drug development and approval processes to identify potential safety issues and optimize treatment strategies.
OMOP #
Observational Medical Outcomes Partnership is a standard that enables the standardized analysis of observational data, which is essential in the approval process of new drugs.
PCA #
Principal Component Analysis is a statistical method that is used to reduce the dimensionality of large datasets, which is essential in the analysis and interpretation of clinical trial data. Related terms include machine learning, data mining, and predictive analytics.
PD #
Pharmacodynamics is the study of the effects of a drug on the body, which is essential in the development and approval of new drugs. Related terms include pharmacokinetics, toxicology, and clinical pharmacology.
Pharmacogenomics #
Pharmacogenomics is the study of the relationship between genetic variation and drug response, which is essential in the development and approval of new drugs. Related terms include personalized medicine, genetic testing, and targeted therapy.
PK #
Pharmacokinetics is the study of the absorption, distribution, metabolism, and excretion of a drug, which is essential in the development and approval of new drugs. Related terms include pharmacodynamics, toxicology, and clinical pharmacology.
PM #
Performance Metric is a measure that is used to evaluate the performance of a machine learning model, which is essential in the integration of AI applications in drug development and approval processes. Related terms include accuracy, precision, and recall.
Precision Medicine #
Precision medicine is an approach to medicine that involves the use of genetic and molecular data to tailor treatment to individual patients, which is essential in the development and approval of new drugs. Related terms include pharmacogenomics, personalized medicine, and targeted therapy.
Protocol #
A protocol is a document that outlines the procedures for a clinical trial, which is essential in the conduct of clinical trials.
QDA #
Query and Data Analysis is a process that involves the analysis of data to answer specific questions, which is essential in the integration of AI applications in drug development and approval processes.
QOL #
Quality of Life is a measure that is used to evaluate the impact of a disease or treatment on a patient's quality of life, which is essential in the development and approval of new drugs. Related terms include patient-reported outcomes, clinical outcomes, and health-related quality of life.
R: R is a programming language that is commonly used for statistical anal… #
Related terms include Python, SAS, and SQL.
Randomization #
Randomization is the process of assigning participants to treatment groups by chance, which is essential in the conduct of clinical trials. Related terms include blinding, stratification, and blocking.
ROC #
Receiver Operating Characteristic is a statistical method that is used to evaluate the accuracy of a diagnostic test, which is essential in the analysis and interpretation of clinical trial data.
RP #
Regulatory Pathway is a process that involves the submission of a regulatory application to obtain approval for a new drug, which is essential in the approval process of new drugs.
SDV #
Source Data Verification is the process of verifying the accuracy of data against the original source, which is essential in the integration of AI applications in drug development and approval processes.
SNP #
Single Nucleotide Polymorphism is a type of genetic variation that involves a change in a single nucleotide, which is essential in the development and approval of new drugs.
SOP #
Standard Operating Procedure is a document that outlines the procedures for a specific task or process, which is essential in the conduct of clinical trials.
SQL #
Structured Query Language is a programming language that is commonly used for database management, which is essential in the integration of AI applications in drug development and approval processes.
Statistics #
Statistics is the science of collecting, analyzing, and interpreting data, which is essential in the analysis and interpretation of clinical trial data.
Study Protocol #
A study protocol is a document that outlines the procedures for a clinical trial, which is essential in the conduct of clinical trials.
Surrogate Endpoint #
A surrogate endpoint is a measure that is used to evaluate the effectiveness of a treatment, which is essential in the development and approval of new drugs. Related terms include clinical endpoint, biomarker, and pharmacodynamic marker.
SW #
Software is a program that is used to perform a specific task or function, which is essential in the integration of AI applications in drug development and approval processes.
Systems Biology #
Systems biology is the study of complex biological systems, which is essential in the development and approval of new drugs.
Targeted Therapy #
Targeted therapy is a type of treatment that involves the use of a specific drug or intervention to target a specific disease or condition, which is essential in the development and approval of new drugs. Related terms include pharmacogenomics, personalized medicine, and precision medicine.
TLV #
Therapeutic Laboratory Value is a measure that is used to evaluate the effectiveness of a treatment, which is essential in the development and approval of new drugs.
Toxicology #
Toxicology is the study of the adverse effects of a substance on the body, which is essential in the development and approval of new drugs. Related terms include pharmacology, pharmacokinetics, and pharmacodynamics.
UAT #
User Acceptance Testing is the process of testing a system or application to ensure that it meets the user's requirements, which is essential in the integration of AI applications in drug development and approval processes.
USP #
United States Pharmacopeia is a standard that provides a set of guidelines for the manufacture and testing of pharmaceuticals, which is essential in the approval process of new drugs.
Validation #
Validation is the process of evaluating the performance of a machine learning model, which is essential in the integration of AI applications in drug development and approval processes.
Web Services #
Web services are a type of software that enables the exchange of data between different systems, which is essential in the integration of AI applications in drug development and approval processes.
WHO #
World Health Organization is an organization that develops and maintains guidelines for the development and approval of new drugs, which is essential in the approval process of new drugs. Related terms include FDA, EMA, and regulatory affairs.
XML #
Extensible Markup Language is a programming language that is commonly used for data exchange, which is essential in the integration of AI applications in drug development and approval processes.